Aroa Biosurgery Ltd Ordinary Shares ARX
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- A$0.50
- Day Range
- A$0.49–0.54
- 52-Week Range
- A$0.48–1.09
- Bid/Ask
- A$0.49 / A$0.51
- Market Cap
- A$175.55 Mil
- Volume/Avg
- 103,768 / 316,787
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 2.89
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Aroa Biosurgery Ltd is a soft tissue regeneration company which develops, manufactures and sells medical devices for wound and soft tissue repair using its proprietary extracellular matrix (ECM) technology. It is focused on improving the rate and quality of healing in complex wounds and soft tissue reconstruction. The Company is in the business of developing, manufacturing and selling soft tissue repair products. The company's principal market is the United States where it has five key products for sale targeting chronic wounds, hernia, plastics, reconstructive surgery and trauma/limb salvage/tumor surgery.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Growth
- Total Number of Employees
- —
- Website
- https://www.aroabio.com
Comparables
Valuation
|
Metric
|
ARX
|
603301
|
SIBN
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 7.73 | — |
Price/Book Value | 1.93 | 1.00 | 3.66 |
Price/Sales | 2.89 | 1.07 | 4.22 |
Price/Cash Flow | — | 4.58 | — |
Price/Earnings
ARX
603301
SIBN
Financial Strength
|
Metric
|
ARX
|
603301
|
SIBN
|
|---|---|---|---|
Quick Ratio | 5.57 | 1.50 | 8.01 |
Current Ratio | 7.83 | 2.21 | 9.01 |
Interest Coverage | — | 24.52 | −13.52 |
Quick Ratio
ARX
603301
SIBN
Profitability
|
Metric
|
ARX
|
603301
|
SIBN
|
|---|---|---|---|
Return on Assets (Normalized) | — | 6.78% | −8.97% |
Return on Equity (Normalized) | — | 9.61% | −12.61% |
Return on Invested Capital (Normalized) | — | 8.71% | −11.78% |
Return on Assets
ARX
603301
SIBN
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Swlvrtb | Nbwcv | $185.4 Bil | |
SYK
| Stryker Corp | Blqbngyh | Xvj | $128.2 Bil | |
BSX
| Boston Scientific Corp | Ghhnqtjq | Xkftf | $107.7 Bil | |
MDT
| Medtronic PLC | Vcgrnqzvt | Thrylbj | $105.2 Bil | |
DXCM
| DexCom Inc | Mgxbrqtt | Jvss | $54.7 Bil | |
EW
| Edwards Lifesciences Corp | Mfvkmynb | Ysrplkm | $52.8 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Lfcpqgxczd | Zxbqn | $24.6 Bil | |
ALGN
| Align Technology Inc | Lndbhwhv | Yznxjy | $23.4 Bil | |
PHG
| Koninklijke Philips NV ADR | Hnwscnjb | Yqqfzcr | $18.7 Bil | |
PODD
| Insulet Corp | Mwzdwnsp | Qdbbtj | $11.5 Bil |